Peptide Developability at the Discovery-to-Development Interface—Current State and Future Opportunities Annette BakWeiguo Dai Editorial 31 March 2015 Pages: 777 - 779
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases M. Elizabeth MeredithTherese S. SalamehWilliam A. Banks Review Article 24 March 2015 Pages: 780 - 787
Molecular Imaging of Membrane Transporters’ Activity in Cancer: a Picture is Worth a Thousand Tubes Aniv MannInessa SemenenkoSara Eyal Review Article 31 March 2015 Pages: 788 - 801
Multidrug Resistance Proteins (MRPs) and Cancer Therapy Yun-Kai ZhangYi-Jun WangZhe-Sheng Chen Review Article 04 April 2015 Pages: 802 - 812
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases Meghna TalekarThanh-Huyen TranMansoor Amiji Review Article 29 April 2015 Pages: 813 - 827
Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection S. SadekarI. FigueroaM. Tabrizi Review Article 02 May 2015 Pages: 828 - 836
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches Ben ForbesPer BäckmanBeth Morgan Review Article 05 May 2015 Pages: 837 - 852
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs Jens Markus BorghardtBenjamin WeberCharlotte Kloft Review Article 07 April 2015 Pages: 853 - 870
In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers Stephen T. HorhotaJan A. van NoordPiet J. G. Cornelissen Research Article 21 March 2015 Pages: 871 - 880
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 Nageshwar R. BudhaMaya LeabmanJohn D. Davis Research Article 31 March 2015 Pages: 881 - 890
A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion Wenlei JiangFairouz MakhloufRobert Lionberger Research Article 04 April 2015 Pages: 891 - 901
Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs Mary S. KleppeKelly M. Forney-StevensRobin H. Bogner Research Article 08 April 2015 Pages: 902 - 917
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer Raúl OrtizLaura CabezaJose Prados Research Article 17 April 2015 Pages: 918 - 929
Anti-repulsive Guidance Molecule C (RGMc) Antibodies Increases Serum Iron in Rats and Cynomolgus Monkeys by Hepcidin Downregulation Preethne BöserDietmar SeemannBernhard K. Mueller Research Article Open access 22 April 2015 Pages: 930 - 938
Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation John F. MarcellettiCindy L. EvansAdriana E. Lopez Research Article 23 April 2015 Pages: 939 - 947
Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls Mark G. PapichMarilyn N. Martinez Research Article 29 April 2015 Pages: 948 - 964
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat Gurkishan S. ChadhaMarilyn E. Morris Research Article 30 April 2015 Pages: 965 - 975
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay Yan G. NiXiling YuanSteven P. Piccoli Research Article 01 May 2015 Pages: 976 - 987
Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models Neil MathiasYan XuMunir Hussain Research Article 02 May 2015 Pages: 988 - 998
A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach Benjamin WeberGuenther Hochhaus Research Article 02 May 2015 Pages: 999 - 1010
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference Lawrence X. YuJeffrey BakerSivakumar Vaithiyalingam Meeting Report 04 April 2015 Pages: 1011 - 1018
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment Marian KelleyLauren StevensonBinodh DeSilva Meeting Report 30 April 2015 Pages: 1019 - 1024
Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates Sebastian PolakMichael K. PugsleyBarbara Wiśniowska Meeting Report Open access 05 May 2015 Pages: 1025 - 1032
On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs S. Morales-AlcelayJ. M. de la Torre de AlvaradoA. García-Arieta Regulatory Note 19 March 2015 Pages: 1033 - 1034
Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case Studies Paramjeet KaurXiaojian JiangEthan Stier BriefCommunication 22 April 2015 Pages: 1035 - 1039